1. Home
  2. KNSA vs BETA Comparison

KNSA vs BETA Comparison

Compare KNSA & BETA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kiniksa Pharmaceuticals Ltd.

KNSA

Kiniksa Pharmaceuticals Ltd.

HOLD

Current Price

$77.47

Market Cap

4.9B

Sector

Health Care

ML Signal

HOLD

Logo Beta Technologies Inc.

BETA

Beta Technologies Inc.

HOLD

Current Price

$24.38

Market Cap

5.4B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
KNSA
BETA
Founded
2015
2017
Country
United Kingdom
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Aerospace
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
4.9B
5.4B
IPO Year
2018
2025

Fundamental Metrics

Financial Performance
Metric
KNSA
BETA
Price
$77.47
$24.38
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
7
8
Target Price
$60.86
$35.25
AVG Volume (30 Days)
686.4K
1.3M
Earning Date
04-28-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
225.00
N/A
EPS
0.27
N/A
Revenue
$677,564,000.00
$35,616,000.00
Revenue This Year
$37.48
$14.75
Revenue Next Year
$17.87
$918.13
P/E Ratio
$285.48
N/A
Revenue Growth
60.09
135.99
52 Week Low
$32.69
$13.43
52 Week High
$82.94
$36.43

Technical Indicators

Market Signals
Indicator
KNSA
BETA
Relative Strength Index (RSI) 65.81 76.01
Support Level $40.06 $14.52
Resistance Level $82.94 $31.16
Average True Range (ATR) 3.75 1.40
MACD 0.20 0.60
Stochastic Oscillator 76.67 93.26

Price Performance

Historical Comparison
KNSA
BETA

About KNSA Kiniksa Pharmaceuticals Ltd.

Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating cardiovascular diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and Vixarelimab. Geographically, the company earns maximum revenue from United States.

About BETA Beta Technologies Inc.

BETA Technologies Inc is an aerospace company. The group has developed an electric aircraft platform and propulsion systems that are positioned to transform the aviation industry forward into a new phase of growth. It designs, manufactures, and sells high-performance electric aircraft, modern electric propulsion systems, charging systems, and components. The group also invested in the underlying infrastructure of this breakthrough technology, which is critical to bringing electric aviation to life. The group has developed a differentiated presence in North America and is well-positioned to expand globally. Its products and services are Aircraft, Charge, Motor, Battery, Flight Controls, and Training. It has one operating segment: Development and Manufacturing of Electric Aircraft.

Share on Social Networks: